This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignee: Spur Therapeutics Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jenny Mcintosh: Innovator in Polynucleotide Research
Introduction
Jenny Mcintosh is a prominent inventor based in Epsom, GB. She has made significant contributions to the field of biotechnology, particularly in the area of polynucleotides. Her innovative work has led to the development of a patent that showcases her expertise and dedication to advancing scientific knowledge.
Latest Patents
Jenny holds a patent related to polynucleotides, specifically those comprising a GBA nucleotide sequence that encodes a GCase protein or a fragment thereof. This invention is notable for including a portion of the coding sequence that is not wild type. Additionally, her patent encompasses viral particles that contain a recombinant genome comprising the polynucleotide, as well as various compositions and methods for utilizing these polynucleotides and viral particles.
Career Highlights
Throughout her career, Jenny has demonstrated a strong commitment to research and innovation. She is currently associated with Spur Therapeutics Limited, where she continues to explore the potential applications of her inventions. Her work has not only contributed to scientific advancements but has also opened new avenues for therapeutic development.
Collaborations
Jenny collaborates with various professionals in her field, including her coworker Romuald Corbau. These partnerships enhance her research efforts and foster a collaborative environment that encourages innovation.
Conclusion
Jenny Mcintosh is a trailblazer in the field of polynucleotide research, with a patent that highlights her innovative contributions. Her work at Spur Therapeutics Limited and collaborations with other professionals underscore her commitment to advancing biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile